Precision Neuroscience Secures $250M Series D Round
Article excerpt
Highlighted: the sentence this signal was extracted from
Precision Neuroscience raised $250 million in a Series D funding round led by Pershing Square to advance its minimally invasive brain-computer interface technology. Medical device developer Precision Neuroscience has raised 250 million dollars in an oversubscribed Series D funding round to accelerate the development of its brain-computer interface technology. The round was co-led by Bill Ackman 's Pershing Square Inc., the Ackman Oxman Institute, and an undisclosed life sciences fund. The late
